Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fan Xia
Institution:
First Affiliated Hospital of Soochow University
Observed institution:
First Affiliated Hospital of Soochow University
ORCID:
0000-0002-5069-3365
Observed ORCID:
0000-0002-5069-3365
OpenAlex ID:
A5023486533
Overall survival benefits provided by lenalidomide maintenance after chimeric antigen receptor T cell therapy in patients with refractory/relapsed diffuse large B-cell lymphoma
2022
·
Nana Ping
, Changju Qu
, et al.
·
Annals of Translational Medicine
·
25
PDF
A model based on machine learning for the prediction of cyclosporin A trough concentration in Chinese allo-HSCT patients
2022
·
Lin Song
, Chen-Rong Huang
, et al.
·
Expert Review of Clinical Pharmacology
·
12
Dual epigenetic agents plus rituximab–gemcitabine–oxaliplatin as salvage treatment in relapsed/refractory diffuse large B‐cell lymphoma patients failure of salvage chemotherapy
2022
·
Changju Qu
, Nana Ping
, et al.
·
Hematological Oncology
·
8
Epigenetic priming with azacitidine-BEAM versus decitabine-BEAM conditioning for autologous transplantation in non-Hodgkin’s lymphoma
2026
·
Jiajie Tu
, Rui Zou
, et al.
·
Bone Marrow Transplantation
A UHPLC-MS/MS method for the simultaneous quantification of BTK inhibitors and their active metabolite in human plasma and cerebrospinal fluid
2026
·
Sijia Li
, Jiameng Xie
, et al.
·
Bioanalysis
[The Impact of CD4+/CD8+ Ratio on the Efficacy of CAR-T Therapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma].
2026
·
Fan Xia
, Qian Zhu
, et al.
·
PubMed
Long‐Term Follow‐Up of Chidamide With Chemotherapy in Untreated Peripheral T‐Cell Lymphoma: One Single Center Real‐World Study in China
2026
·
Jiajie He
, Fan Xia
, et al.
·
Hematological Oncology
Show more works
View as search
Works count:
7
Citation count:
45
H-index:
3
I10-index:
2
Year
Topic
Type